Rift Valley Fever Virus: A Virus with Potential for Global Emergence

The Role of Animals in Emerging Viral Diseases

Volumn , Issue , 2013, Pages 169-200

  Paweska, Janusz T ^a,b   Jansen van Vuren, Petrus ^a  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Bunyavirus; Epidemiology; Reservoir hosts; Rift Valley fever virus; Vectors; Virus transmission

Indexed keywords

EID: 84897780504     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-405191-1.00008-9     Document Type: Chapter

References (142)

1. Andriamandimby S., Randrianarivo-Solofoniaina A., Jeanmaire E., Ravolomanana L., Razafimanantsoa L., Rakotojoelinandrasana T., Razainirina J., Hoffman J., Ravalohery J.-P., Rafisandratantsoa J.-T., Rollin P.E., Reynes J.-M. Rift Valley fever during rainy seasons, Madagascar, 2008 and 2009. Emerg. Infect. Dis. 2010, 16:963-970.
2. Anderson G.W., Rowe L.W. The prevalence of antibody to the viruses of bovine virus diarrhoea, bovine herpers virus 1, Rift Valley fever, ephemeral fever and bluetongue and to Leptospira spp. in free-ranging wildlife in Zimbabwe. Epid. Infect. 1998, 121:441-449.
3. Archer B.N., Weyer J., Paweska J., Nkosi D., Leman P., San Tint K., Blumberg L. Outbreak of Rift Valley fever affecting veterinarians and farmers in South Africa, 2008. S. Afr. Med. J. 2011, 101:263-266.
4. Billecocq A., Spiegel M., Vialat P., Kohl A., Weber F., Bouloy M., Haller O. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J. Virol. 2004, 78:9798-9806.
5. Bird B.H., Nichol S.T. Breaking the chain: Rift Valley fever virus control via livestock vaccination. Curr. Opin. Virol. 2012, 2:315-323.
6. Bird B.H., Khristova M.L., Rollin P.E., Ksiazek T.G., Nichol S.T. Complete genome analysis of 33 ecologically and biologically diverse Rift Valley Fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry. J. Virol. 2007, 81:2805-2816.
7. Bird B.H., Githinji J.W.K., Macharia J.M., Kasiiti J.L., Muriithi R.M., Gacheru S.G., Musaa J.O., Towner J.S., Reeder S.A., Oliver J.B., Stevens T.L., Erickson B.R., Morgan L.T., Khristova M.L., Hartman A.L., Comer J.A., Rollin P.E., Ksiazek T.G., Nichol S.T. Multiple virus lineages sharing recent common ancestry were associated with a large Rift Valley fever outbreak among livestock in Kenya during 2006-2007. J. Virol. 2008, 82:11152-11166.
8. Bird B.H., Maartens L.H., Campbell S., Erasmus B.J., Erickson B.R., Dodd K.A., Spiropoulou C.F., Cannon D., Drew C.P., Knust B., McElroy A.K., Khristova M.L., Albarino C.G., Nichol S.T. Rift Valley fever virus lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep. J. Virol. 2011, 85:12901-12909.
9. Boiro I.O., Konstaninov K., Numerov A.D. Isolation of Rift Valley fever virus from bats in Republic of Guinea. Bull. Soc. Pathol. Exot. 1987, 80:62-67.
10. Borucki M.K., Chandler L.J., Parker B.M., Blair C.D., Beaty B.J. Bunyavirus superinfection and segment reassortment in transovarially infected mosquitoes. J. Gen. Virol. 1999, 80:3173-3179.
11. Boshra H., Lorenzo G., Busquets N., Brun A. Rift Valley Fever: Recent Insights into Pathogenesis and Prevention. J. Virol. 2011, 85:60-6105.
12. Botros B., Omar A., Elian K., Mohamed G., Soliman A., Salib A., Salman D., Saad M., Earhart K. Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine. J. Med. Virol. 2006, 78:787-791.
13. Bouloy M., Flick R. Reverse genetics technology for Rift Valley fever virus: Current and future applications for the development of therapeutics and vaccines. Antiviral Res. 2009, 84:101-118.
14. Bouloy M., Weber F. Molecular biology of Rift Valley fever virus. Open Virol. J. 2010, 4:8-14.
15. Brennan B., Welch S.R., McLees A., Elliott R.M. Creation of a recombinant Rift Valley fever virus with a two-segmented genome. J. Virol. 2011, 85:10310-10318.
16. Briese T., Bird B.H., Kapoor V., Nichol S.T., Lipkin W.I. Batai and Ngari viruses: M segment reassortment and association with severe febrile disease outbreaks in East Africa. J. Virol. 2006, 80:5627-5630.
17. Carroll S.A., Reynes J.M., Khristova M.L., Andriamandimby S.F., Rollin P.E., Nichol S.T. Genetic evidence for Rift Valley fever outbreaks in Madagascar resulting from virus introductions from the East African mainland rather than enzootic maintenance. J. Virol. 2011, 85:6162-6267.
18. Prevalence of Rift Valley fever among ruminants, Mayotte
19. Chevalier V., Pepin M., Plee L., Lancelot R. Rift Valley fever-a threat for Europe?. EuroSurveillance 2010, 15:1950-1956.
20. Clements A.C., Pfeiffer D.U. Emerging viral zoonoses: frameworks for spatial and spatiotemporal risk assessment and resource planning. Vet. J. 2009, 182:21-30.
21. Coetzer J.A. The pathology of Rift Valley fever. II. Lesions occurring in field cases in adult cattle, calves and aborted foetuses, Onderstepoort J. Vet. Res. 1982, 49:11-17.
22. Crabtree M.B., Kent, Crockett R.J., Bird B.H., Nichol S.T., Erickson B.R., Biggerstaff B.J., Horiuchi K., Miller B.R. Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection. PLoS Negl. Trop. Dis. 2012, 6:e1639.
23. Daubney R., Hudson J.R., Garnham P.C. Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep, cattle and man from East Africa. J. Pathol. Bacteriol. 1931, 34:545-579.
24. Davies F.G. Observations on the epidemiology of Rift Valley fever in Kenya. J. Hyg. 1975, 75:219-230.
25. Davies F.G. The historical and recent impact of Rift Valley fever in Africa. Am. J. Trop. Med. Hyg. 2010, 83(Suppl. 2):73-74.
26. Davies F.G., Addy P.A. Rift Valley fever. A survey for antibody to the virus in bird species commonly found in situations considered to be enzootic. Trans. R. Soc. Trop. Med. Hyg. 1979, 73:584-585.
27. Davies F.G., Clausen B., Lund L.J. The pathogenicity of Rift Valley fever virus for the baboon. Trans. R. Soc. Trop. Med. Hyg. 1972, 66:363-365.
28. Davies F.G., Karstad L. Experimental infection of the African buffalo with the virus of Rift Valley fever. Trop. Anim. Health Prod. 1981, 13:185-188.
29. Davies F.G., Koros J., Mbugua H. Rift Valley fever in Kenya: The presence of antibody to the virus in camels (Camelus dromedarius). J. Hyg. 1985, 94:241-244.
30. Diallo M., Nabeth P., Ba K., Sall A.A., Ba Y., Mondo M., Girault L., Abdalahi M.O., Mathiot C. Mosquito vectors of the 1998-1999 outbreak of Rift Valley Fever and other arboviruses (Bagaza, Sanar, Wesselsbron and West Nile) in Mauritania and Senegal. Med. Vet. Entemol. 2005, 19:119-126.
31. Diop G., Thiongane Y., Thonnon J., Fontenille D., Diallo M., Sall S., Ruel T.D., Gonzalez J.P. The potential role of rodents in the enzootic cycle of Rift Valley fever virus in Senegal. Microb. Infect. 2000, 2:343-346.
32. Dodd K.A., Bird B.H., Metcalfe M.G., Nichol S.T., Albarino C.G. Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge. J. Virol. 2012, 86:4204-4212.
33. Easterday B.C. Rift Valley fever. Adv. Vet. Sci. 1965, 10:65-127.
34. Easterday B.C., Murphy L.C., Bennet D.G. Experimental Rift Valley fever in calves, goats and pigs. Am. J. Vet. Res. 1962, 23:1225-1230.
35. Eisa M. Preliminary survey of domestic animals in the Sudan for precipitating antibodies to Rift Valley fever virus. J. Hyg. 1984, 93:629-637.
36. Evans A., Gakuya F., Paweska J.T., Rostal M., Akoolo L., Jansen Van Vuren P., Manyibe T., Macharia J.M., Kziazek T.G., Feiken D.R., Reiman R.F.K., Njenga M.K. Prevalence of antibodies against Rift Valley Fever virus in Kenyan wildlife. Epidemiol. Infec. 2008, 136:1261-1269.
37. Ezeifeka G.O., Umoh J.U., Belino E.D., Ezeokoli C.D. A serological survey for Rift Valley fever antibody in food animals in Kaduna and Sokoto States of Nigeria. Int. J. Zoonoses 1982, 9:147-151.
38. Fafetine J., Neves L., Thompson P.N., Paweska J.T., Victor P.M.G., Rutten V.P.M.G., Coetzer J.A.W., J.A.W. Serological evidence of Rift Valley fever virus circulation in sheep and goats in Zambézia Province, Mozambique. PLoS Negl. Trop. Dis. 2013, 7:e2065.
39. Favier C., Chalvet-Monfray K., Sabatier P., Lancelot R., Fontenille E., Dubois M.A. Rift Valley fever in West Africa: the role of space in endemicity. Trop. Med. Int. Health 2006, 11:1878-1888.
40. Filone C.M., Heise M., Doms R.W., Bertolotti-Ciarlet A. Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors. Virol. 2006, 356:155-164.
41. Findlay G.M. The virus of Rift Valley fever or enzootic hepatitis. Trans. R. Soc. Trop. Med. Hyg. 1931, 25:229-262.
42. Findlay G.M. The infectivity of Rift Valley fever for monkeys. Trans. R. Soc. Trop. Med.Hyg. 1932, 26:161-168.
43. Findlay G.M., Daubney R. The virus of Rift Valley fever or enzootic hepatitis. Lancet 1931, 221:1350-1351.
44. Fontana J., Lopez-Montero N., Elliott R.M., Fernandez J.J., Risco C. The unique architecture of Bunyamwera virus factories around the Golgi complex. Cell. Microbiol. 2008, 10:2012-2028.
45. Fontenille D., Traore-Lamizana M., Diallo M., Thonnon J., Digoutte J.P., Zeller H.G. New Vectors of Rift Valley Fever in West Africa. Emerg. Infect. Dis. 1998, 4:289-293.
46. Gad A.M., Feinsod F.M., Allam I.H., Eisa M., Hassan A.N., Soliman B.A., El Said S., Saah A.J. A possible route for the introduction of Rift Valley fever virus into Egypt during 1977. J. Trop. Med. Hyg. 1986, 89:233-236.
47. Gear J., De Meillon B., Le Roux A.F., Kofsky R., Innes R.R., Steyn J.J., Oliff W.D., Schulz K.H. Rift valley fever in South Africa: a study of the 1953 outbreak in the Orange Free State, with special reference to the vectors and possible reservoir hosts. S. Afr. Med. J. 1955, 29:514-518.
48. Gerrard S.R., Li L., Barrett A.D., Nichol S.T. Ngari virus is a Bunyamwera virus reassortant that can be associated with large outbreaks of hemorrhagic fever in Africa. J. Virol. 2004, 78:8922-8926.
49. Gerrard S.R., Bird B.H., Albarino C.G., Nichol S.T. The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection. Virol. 2007, 359:459-465.
50. Gerrard S.R., Nichol S.T. Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins. Virol. 2007, 357:124-133.
51. Gray K.K., Worthu M.N., Juelich T.L., Agar S.L., Pousssard A., Ragland D., Freiberg A.N., Holbrook M.R. Chemotactic and inflamatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse. PLoS Negl. Trop. Dis. 2012, 6:e1529.
52. Grobbelaar A.A., Weyer J., Leman P.A., Kemp A., Paweska J.T., Swanepoel R. Molecular epidemiology of Rift Valley fever virus. Emerg. Infect. Dis. 2011, 12:2270-2276.
53. Habjan M., Pichlmair A., Elliott R.M., Overby A.K., Glatter T., Gstaiger M., Superti-Furga G., Unger H., Weber F. NSs protein of Rift Valley Fever Virus induces the specific degradation of the double-stranded RNA-dependent protein kinase (PKR). J. Virol. 2009, 83:4365-4375.
54. Hayes E.B. Is it time for a new yellow fever vaccine?. Vaccine 2010, 28:8073-8076.
55. Heinrich N., Saathoff E., Weller N., Clowes P., Kroidl I., Ntinginya E., Machibya H., Maboko L., Lösche R.T., Dobler G., Hoelscher M. High seroprevalence of Rift Valley fever and evidence for endemic circulation in Mbeya region, Tanzania, in a cross-sectional study. PLoS Negl. Trop. Dis. 2012, 6:e1557.
56. Hoogstraal H., Meegan J.M., Khalil G.M. The Rift Valley fever epizootic in Egypt 1977-78. II. Ecological and entomological studies. Trans. R. Soc. Trop. Med. Hyg. 1979, 73:624-629.
57. House C., Alexander K.A., Kat P.W., O'Brien S.J., Mangiafico J. Serum antibody to Rift Valley fever virus in African carnivores. Ann. N.Y. Acad. Sci. 1996, 791:345-349.
58. Ikegami T. Molecular biology and genetic diversity of Rift Valley fever virus. Antiviral Res. 2012, 95:293-310.
59. Ikegami T., Makino S. The pathogenesis of Rift Valley fever. Viruses 2011, 3:493-519.
60. Ikegami T., Narayanan K., Won S., Kamitani W., Peters C.J., Makino S. Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog. 2009, 5:e1000287.
61. Imam Z.E., El-Karamany R., Darwish M.A. An epidemic of Rift Valley fever in Egypt, 2. Isolation of the virus from animals. Bull. WHO 1979, 57:441-443.
62. Jansen van Vuren P., Tiemessen C.T., Paweska J.T. Anti-nucleocapsid immune responses counteract pathogenic effects if Rift Valley fever virus infection in mice. PLoS ONE 2011, 6:e2507.
63. Jouan A., Le Guenno B., Digoutte J.P., Philippe B., Riou O., Adam F. An RVF epidemic in southern Mauritania. Ann. Inst. Pasteur Virol. 1988, 139:307-308.
64. Jupp P.G., Kemp A., Grobbelaar A., Leman P., Burt F.J., Alahmed A.M., Al Mujalli D., Al Khamees M., Swanepoel R. The 2000 epidemic of Rift Valley fever in Saudi Arabia: Mosquito vector studies. Med. Vet. Entomol. 2002, 16:245-252.
65. Kamal S.A. Pathological studies on postvaccinal reactions of Rift Valley fever in goats. Virol. J. 2009, 6:94.
66. Kamal S.A. Observations on Rift Valley fever virus and vaccines in Egypt. Virol. J. 2011, 8:532.
67. Kalveram B., Lihoradova O., Ikegami T. NSs protein of Rift Valley fever virus promotes postranslational downregulation of the TFIIH subunit p62. J. Virol. 2011, 85:6234-6243.
68. Keefer G.V., Zebarth G.L., Allen W.P. Susceptibility of dogs and cats to Rift Valley fever by inhalation or ingestion of virus. J. Infec. Dis. 1972, 125:307-309.
69. Konrad S.K., Miller S.N. A temperature-limited assessment of the risk of Rift Valley fever transmission and establishment in the continental United States of America. Geospat. Health 2012, 6:161-170.
70. Kortekaas J., Oreshkova N., Cobos-Jiméez V., Vloet R.P.M., Potgieter C.A., Moormann R.J.M. Creation of a nonspreading Rift Valley fever virus. J. Virol. 2011, 85:12622-12630.
71. Ksiazek T.G., Jouan A., Meegan J.M., Le Guenno B., Wilson M.L., Peters C.J., Digoutte J.P., Guillaud M., Merzoug N.O., Touray E.M. Rift Valley fever among domestic animals in the recent West African outbreak. Res. Virol. 1989, 140:67-77.
72. LaBeaud A.D., Ochiai Y., Peters C.J., Muchiri E.M., King C.H. Spectrum of Rift Valley fever virus transmission in Kenya: insight from three distinct regions. J. Trop. Med. Hyg. 2007, 76:795-800.
73. LaBeaud A.D., Muchiri E.M., Ndzovu M., Mwanje M.T., Muiruri S., Peters C.J., King C.H. Interepidemic Rift Valley fever virus seropositivity, Northeastern Kenya. Emerg. Infect. Dis. 2009, 14:1240-1246.
74. LaBeaud A.D., Cross P.C., Getz W.M., Glinka A., King C.H. Rift Valley fever virus infection in African buffalo (Syncerus caffer) herds in rural South Africa: evidence of interepidemic transmission. Am. J. Trop. Med. Hyg. 2011, 84:641-646.
75. LaBeaud A.D., Muiruri S., Sutherland L.J., Dahir S., Gildengorin G., Morril J., Muchiri E.M., Peters C.J., King C.H. Postepidemic analysis of Rift Valley fever virus transmission in northeastern Kenya: a village cohort study. PLoS Negl. Trop. Dis. 2011, 5:e1265.
76. Lagerqvist N., Moiane B., Bucht G., Fafetine J., Paweska J.T., Lundkvist A., Falk K.I. Stability of a formalin-inactivated Rift Valley Fever vaccine: evaluation of a vaccination campaign for cattle in Mozambique. Vaccine 2012, 30:6534-6540.
77. Le May N., Mansuroglu Z., Leger P., Josse T., Blot G., Billecocq A., Flick R., Jacob Y., Bonnefoy E., Bouloy M. A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathog. 2008, 4:e13.
78. Lihoradowa O., Ikegami T. Modifying the NSs gene to improve live-attenuated vaccine for Rift Valley fever. Exp. Rev. Vac. 2012, 11:1283-2012.
79. Linthicum K.G., Davies F.G., Bailey C.L., Kairo A. Mosquito species succession in a dambo in an East African forest. Mosq. News 1983, 43:464-470.
80. Linthicum K.J., Davies F.G., Kairo A., Bailey C.L. Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from diptera collected during an inter-epizootic period in Kenya. J. Hyg. 1985, 95:197-209.
81. Liu L., Celma C.C.P., Roy P. Rift Valley fever virus structural proteins: Expression, characterization and assembly of recombinant proteins. Virol. J. 2008, 5:82.
82. Logan T.M., Linthicum K.J., Davies F.G., Binepal Y.S., Roberts C.R. Isolation of Rift Valley fever virus from mosquitoes (Diptera: Culicidae) collected during an outbreak in domestic animals in Kenya. J. Med. Entomol. 1991, 28:293-295.
83. _/_mice induced by different DNA vaccination regimes. Vaccine 2010, 28:2937-2944.
84. Lozach P.Y., Kuhbacher A., Meier R., Mancini R., Bitto D., Bouloy M., Helenius A. DC-SIGN as a receptor for phleboviruses. Cell Host Microbe 2011, 10:75-88.
85. Madani T.A., Al-Mazrou Y.Y., Al-Jeffri M.H., Mishkhas A.A., Al-Rabeah A.M., Turkistani A.M., Al-Sayed M.O., Abodahish A.A., Khan A.S., Ksiazek T.G., Shobokshi O. Rift Valley Fever Epidemic in Saudi Arabia: Epidemiological, Clinical, and Laboratory Characteristics. Clin. Infect. Dis. 2003, 37:1084-1092.
86. Mandel R.B., Koukuntla R., Mogler L.J., Carzoli A.K., Freiberg A.N., Holbrook M.R., Martin B.K., Staplin W.R., Vahanian N.N., Link C.J., Flick R. A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge. Virol. 2010, 397:187-198.
87. Mapaco L.P., Coetzer J.A.W., Paweska J.T., Venter E.H. An investigation into outbreak of Rift Valley fever on a cattle farm in Bela-Bela, South Africa, in 2008. J. S. Afr. Vet. Ass. 2012, 83:E1-E7.
88. Mariner J.C., Morrill J., Ksiazek T.G. Antibodies to hemorrhagic fever viruses in domestic livestock in Niger: Rift Valley fever and Crimean-Congo hemorrhagic fever. Am. J. Trop. Med. Hyg. 1995, 53:217-221.
89. Martin V., Chevalier V., Ceccato P., Anyamba A., De Simone L., Lubroth J., de La Rocque S., Domenech J. The impact of climate change on the epidemiology and control of Rift Valley fever. Rev. Sci. Tech. 2008, 27:413-426.
90. Maurice Y. First serologic verification of the incidence of Wesselsbronn's disease and Rift Valley fever in sheep and wild ruminants in Chad and Cameroon. Rev. Elev. Med. Vet. Pays Trop. 1967, 20:395-404.
91. McIntosh B.M., Dickinson D.B., Dos Santos I. Rift Valley fever. 3. Viremia in cattle and sheep. 4. The susceptibility of mice and hamsters in relation to transmission of virus by mosquitoes. J. S. Afr. Vet. Ass. 1973, 44:167-169.
92. Meegan J.M. Rift valley fever in Egypt: an overview of the epizootics in 1977 and 1978. Contributions to Epidemiology and Biostatistics 1981, 100-113. Rift Valley Fever, S. Karger AG, Basel. T.A. Swartz, M.A. Klinberg, N. Goldblum, C.M. Papier (Eds.).
93. Métras R., Porphyre T., Pfeiffer D.U., Kemp A., Thomson P., Collins L.M., White R.G. Exploratory space-time analyses of Rift Valley fever in South Africa in 2008-2011. PLoS Negl. Trop. Dis. 2012, 6:e1808.
94. Miller M., Buss P., Joubert J., Maseko N., Hofmeyer M., Gerdes T. Serosurvey for selected viral agents in white rhinoceros (Ceratotherium simum) in Kruger National Park, 2007. J. Zoo Wildl. Med. 2011, 42:29-32.
95. Mohamed M., Mosha F., Mghamba J., Zaki S.R., Shieh W.-J., Paweska J., Omulo S., Gikundi S., Mmbuji P., Bloland P., Zeidner N., Kalinga R., Breiman R.F., Njenga M.K. Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007. Am. J. Trop. Med. Hyg. 2010, 83(Suppl. 2):22-27.
96. Morrill J.C., Peters C.J. Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent Rift Valley fever virus. J. Infect. Dis. 2011, 204:229-236.
97. Morrill J.C., Ikegami T., Yoshikawa-Iwata N., Lokugamage N., Won S., Teresaki K., Zamoto-Niikura A., Peters C.J., Makino S. Rapid accumulation of virulent Rift Valley fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the M RNA. PLoS ONE 2010, 5:e9986.
98. Morvan J., Saluzzo J.F., Fontenille D., Rollin P.E., Coulanges P. Rift Valley fever on the east coast of Madagascar. Res. Virol. 1991, 142:475-482.
99. Moutailler S., Krida G., Schaffner F., Vazeille M., Failloux A.B. Potential Vectors of Rift Valley Fever Virus in the Mediterranean Region. Vector Borne Zoonotic Dis. 2008, 8:749-754.
100. Moutailler S., Roche B., Thiberge J.M., Caro V., Rougeon F., Failloux A.B. Host alternation is necessary to maintain the genome stability of rift valley fever virus. PLoS Negl. Trop. Dis. 2011, 5:e1156.
101. Muller R., Poch O., Delarue M., Bishop D.H., Bouloy M. Rift Valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases. J. Gen. Virol. 1994, 75:1345-1352.
102. Muller R., Saluzzo J.F., Lopez N., Dreier T., Turell M., Smith J., Bouloy M. Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. Am. J. Trop. Med. Hyg. 1995, 53:405-411.
103. Murithi R.M., Munyua P., Ithondeka P.M., Macharia J.M., Hightower A., Luman E.T., Breiman R.F., Njenga M.K. Rift Valley fever in Kenya: history of epizootics and identification of vulnerable districs. Epidemiol. Infect. 2011, 139:372-380.
104. Munyua P., Murithi R.M., Weinwright S., Githinji J., Hightower A., Mutonga D., Macharia J., Ithodeka P.M., Musaa J., Breiman R.F., Bloland P., Njenga M.K. Rift Valley fever outbreak in Kenya, 2006-2007. Am. J. Trop. Med. Hyg. 2010, 83:58-64.
105. Nabeth P.Y., Kane M.O., Abdalahi M., Diallo K., Ndiaye K.B., Schneegans F., Sall A.A., Mathiot C. Rift Valley fever outbreak, Mauritania, 1998: Seroepidemiologic, virologic entomologic, and zoologic investigations. Emerg. Infect. Dis. 2001, 7:1052-1054.
106. Narayanan A., Kehn-Hall K., Senina S., Hill L., van Duyne R., Guendel I., Das R., Baer A., Bethel L., Turell M., Hartman A.L., Das B., Bailey C., Kashanchi F. Curcumin inhibits Rift Valley fever replication in human cells. J. Biol. Chem. 2012, 40:33198-33214.
107. Nderitu L., Lee J.S., Omolo J., Omulo S., O'Guinn M.L., Hightower A., Mosha F., Mohamed M., Munyua P., Nganga Z., Hiett K., Seal B., Feikin D.R., Breiman R.F., Njenga M.K. Sequential Rift Valley fever outbreaks in Eastern Africa caused by multiple lineages of the virus. J. Infect. Dis. 2011, 203:655-665.
108. Nfon C.K., Marszal P., Zhang S., Weingartl H.M. Innate immune response to Rift Valley fever virus in goats. PLoS Negl. Trop. Dis. 2012, 6:e1623.
109. Nguku P., Sharif S.K., Mutonga D., Amwayi S., Omolo J., Mohamed O., Farnon E.C., Gould L.H., Lederman E., Rao C., Sang R., Schnabel D., Feikin D.R., Hightower A., Njenga M.K., Breiman R.F. An investigation of a major outbreak of Rift Valley fever in Kenya: 2006-2007. Am. J. Trop. Med. Hyg. 2010, 83:5-13.
110. Olive M.-M., Goodman S.M., Reynes J.-M. The role of wild mamals in the maintenance of Rift Valley fever virus. J. Wildl. Dis. 2012, 48:241-266.
111. Oelofsen M.J., Van der Ryst E. Could bats act as reservoir hosts for Rift Valley fever virus?. Onderstepoort J. Vet. Res. 1999, 66:51-54.
112. Pepin M., Bouloy M., Bird B.H., Kemp A., Paweska J. Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet. Res. 2010, 41:61.
113. Piper C.J., Sorenson D.R., Gerrard S.R. Efficient cellular release of Rift Valley fever virus requires genomic RNA. PLoS One 2011, 6:e18070.
114. Pourrut X., Nkoghe D., Souris M., Paupy C., Paweska J., Padilla C., Moussavou G., Leroy R.M. Rift Valley fever seroprevalence in human rural populations of Gabon. PLoS Negl. Trop. Dis. 2010, 4:e763.
115. Pretorius A.M., Oelofsen M.J., Smith M.S., van der Ryst E. Rift Valley fever virus: a seroepidemiologic study of small terrestial vertebrates in South Africa. Am. J. Trop. Med. Hyg. 1997, 57:693-698.
116. Reguera J.F., Weber F., Cusak S. Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription. PLoS Pathog 2010, 6:e1001101.
117. Rich K.M., Wanyoike F. An assessment of the regional and national socio-economic impacts of the 2007 Rift Valley fever outbreak in Kenya. Am. J. Trop. Med. Hyg. 2010, 83:52-57.
118. Rusnak J.M., Gibbs P., Boudreau E., Clizbe D.P., Pittman P. Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study. Vaccine 2011, 29:3222-3229.
119. Sall A.A., Zanotto P.M.D.A., Zeller H.G., Digoutte J.P., Thiongane Y., Bouloy M. Variability of the NSs protein among Rift Valley fever virus isolates. J. Gen. Virol. 1997, 78:2853-2858.
120. Sall A.A., Zanotto P.M.D.A., Sene O.K., Zeller H.G., Digoutte J.P., Thiongane Y., Bouloy M. Genetic reassortment of Rift Valley fever virus in nature. J. Virol. 1999, 73:8196-8200.
121. Schmaljohn C.S., Nichol S.T. Bunyaviridae. Fields Virology 2007, 1741-1789. Lippincott, Williams & Wilkins, Philadelphia, PA, USA. 5th ed. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Straus (Eds.).
122. Scott G.R. Pigs and Rift Valley fever. Nature 1963, 200:919-920.
123. Scott T., Paweska J.T., Arbuthnot P., Weinberg M.S. Pathogenic effects of Rift Valley fever virus NSs gene are alleviated in cultured cells by expressed antiviral short hairpin RNAs. Antivir. Ther. 2012, 17:643-656.
124. Service M.W. Mosquito (Diptera:Culicidae) dispersal-the long and short of it. J. Med. Entomol. 1997, 34:579-588.
125. Sherman M.B., Freiberg A.N., Holbrook M.R., Watowich S.J. Single-particle cryo-electron microscopy of Rift Valley fever virus. Virol. 2009, 387:11-15.
126. Shieh W.-J., Paddock C.D., Lederman E., Rao C.Y., Gould L.H., Mohamed M., Mosha F., Mghamba J., Bloland P., Njenga M.K., Mutonga D., Samuel A.A., Guarner J., Breiman R.F., Zaki S.R. Pathologic studies on suspect animal and human cases of Rift Valley fever from an outbreak in Eastern Africa, 2006-2007. Am. J. Trop. Med. Hyg. 2010, 83:38-42.
127. Smith D.R., Bird B.H., Lewis B., Johnston S.C., McCarthy S., Keeney A., Botto M., Donnelly G., Shamblin J., Albarino C., Nichol S.T., Hensley J.E. Development of a novel nonhuman primate model for Rift Valley fever. J. Virol. 2012, 86:2109-2110.
128. Soumaré P.O.L., Freire C.C.M., Faye O., Diallo M., de Oliveira J.V.C., Zanatto P.M.A., Sall A.A. Phylogeography of Rift Valley fever virus in Africa reveals multiple introductions in Senegal and Mauritania. PLoS ONE 2012, 7:e35216.
129. Struthers J.K., Swanepoel R. Identification of a major non-structural protein in the nuclei of Rift Valley fever virus-infected cells. J. Gen. Virol. 1982, 60:381-384.
130. Swanepoel R., Coetzer J.A. Rift Valley fever. Infectious Diseases of Livestock 2004, 1037-1070. Oxford University Press Southern Africa, Cape Town. J.A. Coetzer, R.C. Tustin (Eds.).
131. Swanepoel R., Paweska J.T. Rift Valley fever. Oxford Textbook of Zoonoses: Biology, Clinical Practise, and Public Health Control 2011, 421-431. Oxford University Press. S.R. Palmer, L. Soulsby, P.R. Torgerson, D.W.G. Brown (Eds.).
132. Swanepoel R., Erasmus B.J., Williams R., Taylor M.B. Encephalitis and chorioretinitis associated with neurotropic African horsesickness virus infection in laboratory workers. Part III. Virological and serological investigations. S. Afr. Med. J. 1992, 81:458-461.
133. Traoré-Lamizana M., Fontenille D., Diall M., Ba Y., Zeller H.R., Mondo M., Adam F., Thonon J., Maiga A. Arbovirus surveillance from 1990 to 1995 in the Barkedji area (Ferlo) of Senegal a possible natural focus of Rift Valley fever virus. J. Med. Entomol. 2001, 38:480-492.
134. Turell M.J., Linthicum K.J., Beaman J.R. Transmission of Rift Valley fever virus by adult mosquitoes after ingestion of virus as larvae. Am. J. Trop. Med. Hyg. 1990, 43:677-680.
135. Turell M.J., Dohm D.J., Mores C.N., Terracina L., Wallette D.L., Hribar L.J., Pecor J.E., Blow J.A. Potential for North American mosquitoes to transmit Rift Valley fever virus. J. Am. Mosquito Control Ass. 2008, 24:502-507.
136. Von Teichman B., Engelbrecht A., Zulu G., Dungu B., Pardini A., Bouloy M. Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves. Vaccine 2011, 29:5771-5777.
137. Walker J.S., Remmele N.S., Carter R.C., Mitten J.Q., Schuh L.G., Stephen E.L., Klein F. The clinical aspects of Rift Valley Fever virus in household pets. I. Susceptibility of the dog. J. Infect. Dis. 1970, 121:9-18.
138. Walker J.S., Stephen E.L., Remmele N.S., Carter R.C., Mitten J.Q., Schuh L.G., Klein F. The clinical aspects of Rift Valley Fever virus in household pets. II. Susceptibility of the cat. J. Infect. Dis. 1970, 121:19-24.
139. Won S., Ikegami T., Peters C.J., Makino S. NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis. J. Virol. 2007, 81:13335-13345.
140. Youssef B.Z. The potential role of pigs in the enzootic cycle of Rift Valley fever at Alexandria Governorate, Egypt. J. Egypt. Public Health Assoc. 2009, 84:331-344.
141. Youssef B.Z., Hadia H.A. The potential role of Rattus rattus in enzootic cycle of Rift Valley fever in Egypt. 1 - Detection of RVF antibodies in R. rattus blood samples by both enzyme-linked immuno sorbent assay (ELISA) and immuno-diffusion technique (ID). J. Egypt. Public Health Assoc. 2001, 76:431-441.
142. Zeller H., Fontenille D., Traorelamizana M., Thiongane Y., Digoutte J.P. Enzootic activity of Rift Valley fever virus in Senegal. Am. J. Trop. Med. Hyg. 1997, 56:265-272.